Why is Valiant Laborato falling/rising?

As of 27-Jun, Valiant Laboratories Ltd is experiencing a price increase, currently at Rs 115.35, reflecting a rise of Rs 2.25 or 1.99%. The stock has shown a positive trend today, having gained after two consecutive days of decline, and opened with a gain of 2.39%. It reached an intraday high of Rs 115.85 and is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite these positive movements, the stock has seen a decrease in delivery volume, which fell by 14.53% compared to the 5-day average, indicating a potential concern regarding investor participation. Additionally, while the stock has outperformed its sector by 1.11%, it has a negative long-term outlook with a return on equity of 0% and a significant decline in net sales and operating profit over the past five years.
In the broader market context, Valiant Laboratories Ltd has outperformed the Sensex in the short term, with a 1-week return of 5.39% compared to the benchmark's 2.00%. However, the stock's year-to-date performance is weaker at 4.15% against the Sensex's 7.58%. The recent increase in institutional investor participation, which has risen by 0.64%, may provide some support for the stock's price, as these investors typically have more resources to analyze company fundamentals. Nonetheless, the stock's long-term fundamentals remain weak, with a concerning negative EBITDA and consistent underperformance against the benchmark over the last three years, which could pose risks to its future price movements.